Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$5.58 - $8.61 $999,902 - $1.54 Million
-179,194 Reduced 62.93%
105,566 $688,000
Q1 2024

May 15, 2024

BUY
$8.32 - $15.45 $1.64 Million - $3.05 Million
197,387 Added 225.91%
284,760 $2.48 Million
Q4 2023

Feb 14, 2024

SELL
$8.79 - $11.51 $382,804 - $501,260
-43,550 Reduced 33.26%
87,373 $999,000
Q2 2023

Aug 14, 2023

SELL
$10.1 - $11.6 $221,553 - $254,457
-21,936 Reduced 14.35%
130,923 $1.39 Million
Q1 2023

May 15, 2023

BUY
$10.37 - $12.56 $1.59 Million - $1.92 Million
152,859 New
152,859 $1.61 Million
Q3 2022

Nov 14, 2022

BUY
$10.14 - $12.38 $1.35 Million - $1.65 Million
133,494 New
133,494 $1.38 Million
Q2 2022

Aug 15, 2022

SELL
$11.05 - $12.72 $946,841 - $1.09 Million
-85,687 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$10.61 - $12.88 $919,887 - $1.12 Million
-86,700 Reduced 50.29%
85,687 $1.08 Million
Q4 2021

Feb 14, 2022

SELL
$10.86 - $13.95 $2.75 Million - $3.53 Million
-253,143 Reduced 59.49%
172,387 $2.01 Million
Q3 2021

Nov 15, 2021

BUY
$11.92 - $13.92 $3.5 Million - $4.09 Million
293,762 Added 222.94%
425,530 $5.56 Million
Q2 2021

Aug 16, 2021

SELL
$10.16 - $13.11 $617,971 - $797,402
-60,824 Reduced 31.58%
131,768 $1.7 Million
Q1 2021

May 17, 2021

BUY
$9.04 - $11.86 $1.74 Million - $2.28 Million
192,592 New
192,592 $2.15 Million
Q4 2020

Feb 16, 2021

SELL
$9.05 - $12.2 $260,214 - $350,786
-28,753 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$8.99 - $10.74 $896,249 - $1.07 Million
-99,694 Reduced 77.61%
28,753 $259,000
Q2 2020

Aug 14, 2020

SELL
$9.14 - $11.97 $416,199 - $545,065
-45,536 Reduced 26.17%
128,447 $1.33 Million
Q1 2020

May 15, 2020

BUY
$8.58 - $14.01 $1.35 Million - $2.21 Million
157,689 Added 967.77%
173,983 $1.76 Million
Q4 2019

Feb 14, 2020

SELL
$8.22 - $14.0 $3.13 Million - $5.33 Million
-380,445 Reduced 95.89%
16,294 $217,000
Q3 2019

Nov 14, 2019

BUY
$8.59 - $10.96 $3.41 Million - $4.35 Million
396,739 New
396,739 $3.41 Million
Q2 2019

Aug 14, 2019

SELL
$9.8 - $12.89 $1.85 Million - $2.43 Million
-188,713 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$8.27 - $12.73 $906,309 - $1.4 Million
109,590 Added 138.51%
188,713 $2.55 Million
Q4 2018

Feb 14, 2019

BUY
$7.8 - $16.13 $358,979 - $742,350
46,023 Added 139.04%
79,123 $820,000
Q3 2018

Nov 14, 2018

BUY
$14.31 - $17.65 $473,661 - $584,215
33,100 New
33,100 $611,000
Q1 2018

May 15, 2018

SELL
$11.13 - $13.63 $199,961 - $244,876
-17,966 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$12.16 - $14.58 $218,466 - $261,944
17,966
17,966 $269,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $645M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.